| 000 | 01511 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516001752.0 | ||
| 264 | 0 | _c20110429 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1365-2230 | ||
| 024 | 7 |
_a10.1111/j.1365-2230.2010.03918.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSebaratnam, D F | |
| 245 | 0 | 0 |
_aReversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus. _h[electronic resource] |
| 260 |
_bClinical and experimental dermatology _cJan 2011 |
||
| 300 |
_a91-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadverse effects |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 |
_aAminoquinolines _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Basal Cell _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImiquimod |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPemphigus _xchemically induced |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aToll-Like Receptor 7 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMartin, L K | |
| 700 | 1 | _aRubin, A I | |
| 700 | 1 | _aTran, K | |
| 700 | 1 | _aPas, H H | |
| 700 | 1 | _aMarr, P J | |
| 700 | 1 | _aEdmonds, J | |
| 700 | 1 | _aMurrell, D F | |
| 773 | 0 |
_tClinical and experimental dermatology _gvol. 36 _gno. 1 _gp. 91-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2230.2010.03918.x _zAvailable from publisher's website |
| 999 |
_c20151791 _d20151791 |
||